Actinium Pharmaceuticals, Inc. (ATNM): Total Assets
$51.77M
As of 2025-12-31
$40.16M
As of 2026-06-30
-23.2%
3-year compound annual growth
-4.9%
5-year compound annual growth
+6.9%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $51.77M | -32.7% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $76.90M | -5.6% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $81.44M | -28.7% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $114.19M | +42.1% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $80.39M | +21.1% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $66.40M | +469.0% | 2022-03-25, Balance as of period end |
| 2019-12-31 | $11.67M | -21.6% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $14.89M | -18.8% | 2020-05-08, Balance as of period end |
| 2017-12-31 | $18.34M | -18.6% | 2019-03-15, Balance as of period end |
| 2016-12-31 | $22.53M | -15.3% | 2018-03-16, Balance as of period end |
| 2015-12-31 | $26.59M | +251.3% | 2017-03-16, Balance as of period end |
| 2014-12-31 | $7.57M | +31.3% | 2016-03-11, Balance as of period end |
| 2013-12-31 | $5.77M | -0.4% | 2015-03-16, Balance as of period end |
| 2012-12-31 | $5.79M | -6.6% | 2014-02-28, Balance as of period end |
| 2011-12-31 | $6.20M | n/m | 2013-03-29, Balance as of period end |
| 2010-12-31 | $150 | n/a | 2012-04-12, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $51.77M | -32.7% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $20.45M | +19.9% |
| iBio, Inc. (IBIO) | 2026-06-30 | $99.11M | +327.5% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $7.61M | +2.6% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.81M | -49.4% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $74.31M | -34.4% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $56.08M | -44.6% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.95M | +3.4% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $116.46M | -22.7% |
Compare ATNM, IXHL, IBIO, SILO side by side · Screen every company in Pharmaceutical Preparations ↗